Clinical Trial Detail

NCT ID NCT01241162
Title Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Louisville
Indications

neuroblastoma

osteosarcoma

synovial sarcoma

rhabdomyosarcoma

Ewing sarcoma

Therapies

Decitabine

Age Groups: child

No variant requirements are available.